Dick Heinegard

Title: The Innovative Contributions of Dick Heinegard

Introduction

Dick Heinegard is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of medicine through his innovative patents. With a total of 6 patents, Heinegard's work focuses on advancing treatments for diseases related to cartilage and age-related conditions.

Latest Patents

One of Heinegard's latest patents involves the modulation of cartilage homeostasis by active domains of cell binding extracellular matrix molecules. This patent describes a linear or cyclic peptide, specifically designed for use in medicine, particularly in the manufacture of a medicament for treating diseases associated with inflammatory-mediated cartilage destruction. The minimal core sequence of the peptide is WLEAK (SEQ ID No. 1), with alternatives including WLEAR (SEQ ID No. 17) and WLDAK (SEQ ID No. 18). Another significant patent focuses on screening assays for binding antagonists of the AMD-associated variant of factor H (H384). This invention aims to identify agents that can preferentially inhibit binding to targets such as heparin of the H384 allotypic variant of human complement Factor H, which is associated with age-related macular degeneration (AMD).

Career Highlights

Throughout his career, Dick Heinegard has worked with various companies, including Anamar Medical AB and Biocarb AB. His innovative work has contributed to advancements in medical treatments and therapies.

Collaborations

Heinegard has collaborated with notable individuals in his field, including Pilar Lorenzo and Bo Cederholm. These collaborations have further enhanced his research and development efforts.

Conclusion

Dick Heinegard's contributions to the field of medicine through his patents demonstrate his commitment to innovation and improving healthcare solutions. His work continues to influence the development of treatments for critical health issues.